Based on the effect of IL-33 or IL-33-induced FCGR3+CD103+ cDC1s on tumor therapy in mice, we propose several approaches to translate the antitumor effect of IL-33 observed in mice to humans (Fig. 5). This evidence concerns the gene IL33 and neoplasm.